Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-24Clinical Trial Update: Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I [Phase 1]
Phase I trial evaluating gemcitabine with ascorbate (vitamin C) and radiation therapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-21Clinical Trial Update: Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? [Phase 3]
Phase 3 trial evaluating whether cefoxitin or piperacillin-tazobactam prophylaxis prevents postoperative surgical site infections after panc…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses [NA]
This clinical trial update indicates completion and results posting for a study of stereotactic radiotherapy using varying biological effect…
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Phase IB Metformin, Digoxin, Simvastatin in Solid Tumors [Phase 1]
Phase Ib study evaluating a combination of metformin, digoxin, and simvastatin in advanced pancreatic cancer and other solid tumors.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC [Phase 2]
A Phase 2 trial evaluating Ampligen plus standard of care versus standard of care alone for locally advanced pancreatic cancer has been susp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers [Phase 1]
A Phase 1 study of AMG 199 in MUC17-positive solid tumors including gastric, gastroesophageal junction, colorectal, and pancreatic cancers h…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of BMS-813160 in combination with chemotherapy or nivolumab for advanced solid tumors has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer [NA]
This trial update describes the effects of zinc supplementation on quality of life in patients with gastrointestinal cancers. The study has …
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. [Phase 2]
Phase 2 clinical trial evaluating AG followed by FOLFIRINOX with a PD-L1 antibody as conversion therapy for borderline resectable and locall…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors [Phase 1]
This update covers a Phase 1 trial of a CAR-T therapy targeting carcinoembryonic antigen (CEA) for CEA-positive advanced solid tumors, curre…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of ABTL0812 in Pancreatic Cancer [Phase 1, Phase 2]
The ABTL0812 pancreatic cancer trial (Phase 1/Phase 2) is suspended.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and tolerability of combining epigenetic and immunomodulating drugs with standard chemot…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation [Phase 1]
Phase 1 dose-escalation study of HBI-2438 in KRAS G12C-mutant solid tumors; the trial is active but not recruiting and targets indications i…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Study of IK-595 in RAS- or RAF-altered Advanced Tumors [Phase 1]
Phase 1 study of IK-595 in Ras- or Raf-altered advanced tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas [Phase 3]
Phase 3 clinical trial evaluating Glubran 2, a modified cyanoacrylate tissue adhesive, for use in soft pancreas during pancreatic and periam…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors [NA]
A clinical trial from Union Hospital is evaluating GPA33-targeted PET imaging in colorectal cancer, gastric cancer, and pancreatic cancer; t…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Stereotactic Centralized Ablative Radiotherapy for Locally Advanced Pancreatic Cancer: A Single-Arm Phase I Safety and Feasibility Study [Phase 1]
This document reports a Phase I safety and feasibility study of stereotactic centralized ablative radiotherapy for locally advanced pancreat…
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY
A completed clinical trial comparing gemcitabine therapy to the FOLFIRINOX regimen for locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer [NA]
A completed clinical trial evaluating escalating doses of stereotactic body radiotherapy for pancreatic cancer; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Cohort Study on Nutritional, Metabolic, and Volumetric Assessment After Pancreaticoduodenectomy
This completed cohort study evaluates nutritional, metabolic, and volumetric outcomes after pancreaticoduodenectomy in patients with periamp…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: TCR-T Cell Therapy on Advanced Solid Tumors [EARLY_Phase 1]
Phase 1 TCR-T cell therapy for pancreatic cancer is currently recruiting at Sun Yat-Sen Memorial Hospital.
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) [Phase 1, Phase 2]
A CD318-targeted CAR-T cell therapy (ResCPa) is being studied in pancreatic cancer patients in Phase 1 and Phase 2, and the trial is not yet…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
An update on IMM-1-104's Phase 1/2a trial in advanced or metastatic solid tumors shows the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncologic Outcomes
This completed trial compared robotic-assisted versus open surgery after neoadjuvant therapy in pancreatic cancer to evaluate safety and onc…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer
A completed clinical trial from Lund University studying chemotherapy, host response, and molecular dynamics in periampullary cancers, inclu…